Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,290
Views
11
CrossRef citations to date
0
Altmetric
Back Matter

Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system

Sjoerd Klarenbeeka Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands;c Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-1891-1940
ORCID Icon,
Chris W. Doornebalb Oncode Institute, Utrecht, The Netherlands;d Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;e Department of Anesthesiology, Amsterdam UMC, Amsterdam, The Netherlands
,
Sjors M. Kasa Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands
,
Nicola Bonzannib Oncode Institute, Utrecht, The Netherlands;f Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands;g ENPICOM, ’s-Hertogenbosch, The Netherlands
,
Jinhyuk Bhina Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands;f Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
,
Tanya M. Braumullera Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands
,
Ingrid van der Heijdena Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands
,
Mark Opdama Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
,
Philip C. Schoutena Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
,
Kelly Kerstenb Oncode Institute, Utrecht, The Netherlands;d Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
,
Roebi de Bruijna Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands;f Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
,
Daniel Zingga Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0001-6450-2534
ORCID Icon,
Julia Yemelyanenkoa Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The Netherlands
,
Lodewyk F.A. Wesselsb Oncode Institute, Utrecht, The Netherlands;f Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands;h Department of EEMCS, Delft University of Technology, Delft, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-1656-6995
ORCID Icon,
Karin E. de Visserb Oncode Institute, Utrecht, The Netherlands;d Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-0293-868X
ORCID Icon &
Jos Jonkersa Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;b Oncode Institute, Utrecht, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9264-9792
ORCID Icon show all
Article: 1724049 | Received 03 Jul 2019, Accepted 04 Dec 2019, Published online: 12 Feb 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Na Li, Zubin Li, Xin Li, Bingjie Chen, Huibo Sun & Kun Zhao. (2021) Identification of An Immune-Related Long Noncoding Rna Signature that Predicts Prognosis in Breast Cancer Patients. Biomarkers in Medicine 15:3, pages 167-180.
Read now

Articles from other publishers (10)

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja Kruger, Onno Bleijerveld, Chiara S. Brambillasca, Justin Sprengers, Bjørn Siteur, Stefano Annunziato, Matthijs J. van Haren, Nathaniel I. Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C. Linn, Epie Boven, Maarten Altelaar, Jos Jonkers, Daniel Zingg & Lodewyk F.A. Wessels. (2023) MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. Journal of Experimental Medicine 220:11.
Crossref
Jason A. Mouabbi, Akshara Singareeka Raghavendra, Roland L. BassettJrJr, Amy Hassan, Debu Tripathy & Rachel M. Layman. (2022) Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies. npj Breast Cancer 8:1.
Crossref
K. Van Baelen, T. Geukens, M. Maetens, V. Tjan-Heijnen, C.J. Lord, S. Linn, F.-C. Bidard, F. Richard, W.W. Yang, R.E. Steele, S.J. Pettitt, C. Van Ongeval, M. De Schepper, E. Isnaldi, I. Nevelsteen, A. Smeets, K. Punie, L. Voorwerk, H. Wildiers, G. Floris, A. Vincent-Salomon, P.W.B. Derksen, P. Neven, E. Senkus, E. Sawyer, M. Kok & C. Desmedt. (2022) Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Annals of Oncology 33:8, pages 769-785.
Crossref
Oriol Bestard & Elena Crespo. (2022) Disarming the Old Foe. Restoring T-Cell Immune Function with mTor-Inhibitors to Tackle Cytomegalovirus Infection. Journal of the American Society of Nephrology 33:1, pages 6-8.
Crossref
Amy E. McCart Reed, Lauren Kalinowski, Peter T. Simpson & Sunil R. Lakhani. (2021) Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Research 23:1.
Crossref
George Sflomos, Koen Schipper, Thijs Koorman, Amanda Fitzpatrick, Steffi Oesterreich, Adrian V. Lee, Jos Jonkers, Valerie G. Brunton, Matthias Christgen, Clare Isacke, Patrick W. B. Derksen & Cathrin Brisken. (2021) Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers 13:21, pages 5396.
Crossref
Rita A. Mukhtar & A. Jo Chien. (2021) Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions. Current Breast Cancer Reports 13:3, pages 164-170.
Crossref
Nikhil Pramod, Akanksha Nigam, Mustafa Basree, Resham Mawalkar, Saba Mehra, Neelam Shinde, Gary Tozbikian, Nicole Williams, Sarmila Majumder & Bhuvaneswari Ramaswamy. (2021) Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer. The Oncologist 26:6, pages e943-e953.
Crossref
Alexandre el Hage & Olivier Dormond. (2021) Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. Cancers 13:6, pages 1359.
Crossref
Aitziber Buqué & Lorenzo Galluzzi. 2021. Carcinogen-driven mouse models of oncogenesis. Carcinogen-driven mouse models of oncogenesis xvii xxv .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.